Implementing a Novel Research Methods Training Curriculum for Fellows With Noha Sharafeldin, MD, MSc, PhD, and Waqas Haque, MD, MPH

At this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, Noha Sharafeldin, MD, MSc, PhD, an Assistant Professor of Hematology and Oncology at The University of Alabama at Birmingham, presented a poster entitled, “Implementing a research methods curriculum for first year hematology oncology fellows.” Following the presentation, she sat down with Oncology Data Advisor Fellows Forum Member Waqas Haque, MD, MPH, to delve deeper into the research.

Listen along to this podcast episode to learn more about:

  • The gaps surrounding formal training in research methods for hematology/oncology fellows
  • What motivated Dr. Sharafeldin to design a research methods curriculum for first-year fellows and how it was implemented
  • What results the curriculum produced in fellows’ knowledge of research methods and their own research projects since its implementation
  • Feedback they have received since implementing the curriculum
  • Advice and encouragement to current and future fellows embarking on their first research project
  • And more!

About Dr. Sharafeldin and Dr. Haque

Noha Sharafeldin, MD, MSc, PhD, is an Assistant Professor of Hematology and Oncology at The University of Alabama at Birmingham. Dr. Sharafeldin’s research focuses on medical education, epidemiology, cancer, and genetics, including recent research on the implications of food access and socioeconomic status for patients with cancer.

Waqas Haque, MD, MPH, is a Hematology/Oncology Fellow at the University of Chicago. He recently completed his Internal Medicine Residency at New York University (NYU) in a Clinical Investigator Track. Dr. Haque has balanced his patient care work with a variety of research projects. During his fellowship training at the University of Chicago, he plans to further his work in innovative clinical trial design, value-based care delivery to cancer patients, and clinical investigation. He is a recipient of the 40 Under 40 in Cancer Award, which recognizes the contributions of rising stars and emerging leaders across the field of oncology.

Related Articles

Responses

Your email address will not be published. Required fields are marked *